All In MedTech

Device Trial Radar · NCT05242367

Electrical Vestibular Nerve Stimulation (VeNS) as a Treatment for PTSD

A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of Post- Traumatic Stress Disorder (PTSD)

Last checked: Nov 20, 2026Latest source record: Jun 4, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingRandomized with 383 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

383

Actual

Start

Feb 13, 2023

Primary completion

Dec 2, 2024

Study completion Dec 2, 2024

Sponsor

Lead sponsor
Neurovalens Ltd.Not on our public-company list
Sponsor type
Industry
Collaborators
University of California, San Diego; Clinical Trial Mentors
First posted
Feb 16, 2022

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Triple (participant, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
No
Who can join
All sexes, from 22 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Trial title: A Randomized, Double Blind Sham Controlled Clinical Trial to Evaluate the Efficacy of Electrical Vestibular Nerve Stimulation (VeNS), Compared to a Sham Control for Treatment of PTSD The aim of this study: To better evaluate the efficacy of non-invasive electrical vestibular nerve stimulation (VeNS) as a method of treating PTSD, as compared to a sham control. Allocation: Randomized to either active device or control device usage. Endpoint classification: Efficacy Study Intervention Model: Parallel Assignment in 1:1 active to control allocation Sample size: The aim is to recruit a total of up to 400 participants. The study will last 12 weeks in total for each subject.

Conditions

  • Post Traumatic Stress Disorder

Interventions

  • Modius Spero active deviceDevice

    Battery powered non-invasive neurostimulation device

  • Sham deviceDevice

    Placebo comparator sham device (no active stimulation)

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Posttraumatic Stress Disorder Checklist PCL-5 scoreTime frame: 12 weeks

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • VA San Diego Healthcare System

    San Diego, California

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.